ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.

Giuditta Illuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.